Delivery Order SPE2DB25D7067-SPE2DB25FSVRH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets in quantities of 28 tablets, with a contract ceiling value of $1,201.82. This firm fixed-price delivery order, which is expected to be completed by August 27, 2025, represents a competitively awarded, non-set-aside procurement with performance taking place at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Junel Fe 1 mg–20 mcg tablets in 28-count packages. This is a firm fixed-price delivery order valued at $1,599.54 with an ultimate completion date of August 7, 2025. The contract was awarded without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,558.38 to AmerisourceBergen Drug Corp for the supply of Junel Fe 1 mg-20 mcg tablets (28-count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside, competitively awarded contract employs firm fixed price pricing and represents a child delivery order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.54 to AmerisourceBergen Drug Corp for the supply of Junel FE 1.5 mg-30 mcg tablets in a 28-count package. This competitively awarded, firm fixed-price contract was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1.5 mg-30 mcg Junel FE tablets (28-count) on August 7, 2025, with a ceiling value of $1,178.79. This non-set-aside, firm fixed-price delivery order is set to be completed by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement under the company's existing contract vehicles with the DLA....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 19, 2025, for the supply of Junel FE 1 mg-20 mcg tablets in a 28-tablet package configuration. This firm fixed-price delivery order, valued at $1,141.06, represents a non-set-aside competitive award with an ultimate completion date of May 20, 2025. The performance location is identified as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $5,800.03 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages) on September 8, 2025, with completion expected by September 9, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is classified as a child contract under a larger vehicle. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,427.92 to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count package) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,810.99 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Junel FE 1 mg-20 mcg tablets in a 28-count package. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract calls for performance completion by September 19, 2025, with the product to be delivered to or performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,587.38 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages) on August 11, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by August 12, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader relationship with the federal government for...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVRHDelivery Order
This delivery order, awarded on August 21, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Junel Fe 1.5 mg-30 mcg tablets in quantities of 28 units, with a ceiling value of $1,344.48. The contract employs firm fixed pricing and is classified as a non-set-aside competitive award. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp leverages this comprehensive global pharmaceutical support vehicle to supply brand-name and generic medications, vaccines, and medical supplies to support military healthcare systems worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. The IDC framework enables the company to fulfill varied federal medical procurement requirements through a flexible contracting mechanism that supports the DLA's Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/21/25 |